AU2020901514A0 - Use of aminoacetonitrile compounds for the treatment of disease - Google Patents

Use of aminoacetonitrile compounds for the treatment of disease

Info

Publication number
AU2020901514A0
AU2020901514A0 AU2020901514A AU2020901514A AU2020901514A0 AU 2020901514 A0 AU2020901514 A0 AU 2020901514A0 AU 2020901514 A AU2020901514 A AU 2020901514A AU 2020901514 A AU2020901514 A AU 2020901514A AU 2020901514 A0 AU2020901514 A0 AU 2020901514A0
Authority
AU
Australia
Prior art keywords
disease
treatment
aminoacetonitrile compounds
aminoacetonitrile
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020901514A
Inventor
Roger Aston
Richard Mollard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pitney Pharmaceuticals Pty Ltd
Original Assignee
Pitney Pharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Pitney Pharmaceuticals Pty Ltd filed Critical Pitney Pharmaceuticals Pty Ltd
Publication of AU2020901514A0 publication Critical patent/AU2020901514A0/en
Priority to US17/924,537 priority Critical patent/US20230181516A1/en
Priority to PCT/AU2021/050435 priority patent/WO2021226662A1/en
Priority to JP2022569454A priority patent/JP2023528229A/en
Priority to CA3183094A priority patent/CA3183094A1/en
Priority to AU2021272252A priority patent/AU2021272252A1/en
Priority to EP21804737.1A priority patent/EP4149454A1/en
Abandoned legal-status Critical Current

Links

AU2020901514A 2020-05-11 2020-05-11 Use of aminoacetonitrile compounds for the treatment of disease Abandoned AU2020901514A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US17/924,537 US20230181516A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease
PCT/AU2021/050435 WO2021226662A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease
JP2022569454A JP2023528229A (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infections and diseases
CA3183094A CA3183094A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease
AU2021272252A AU2021272252A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease
EP21804737.1A EP4149454A1 (en) 2020-05-11 2021-05-11 Use of aminoacetonitrile compounds for the treatment of infection and disease

Publications (1)

Publication Number Publication Date
AU2020901514A0 true AU2020901514A0 (en) 2020-05-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP3781564A4 (en) Compounds for the treatment of cancer
EP3934652A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3790867A4 (en) Kdm1a inhibitors for the treatment of disease
EP3935050A4 (en) Heterocyclic compounds for medical treatment
EP3986863A4 (en) Glycolate oxidase inhibitors for the treatment of disease
EP3955937A4 (en) Compounds and methods for the treatment of ocular disorders
IL276482A (en) Compounds for the treatment of pain
EP3801626A4 (en) Use of riluzole oral disintigrating tablets for treating diseases
EP3836922A4 (en) Use of riluzole oral disintigrating tablets for treating diseases
EP3955926A4 (en) Compounds and methods for the treatment of ocular disorders
EP3755319A4 (en) Compounds and compositions for the treatment of muscular disorders
EP3935037A4 (en) Use of 8,9-dihydrocannabidiol compounds
EP3877382A4 (en) Novel compounds for the treatment of respiratory diseases
EP3911313A4 (en) Thienyl-aniline compounds for treatment of dermal disorders
EP3911160A4 (en) Treatment of plants against disease
EP3741365A4 (en) Urine alkali agent useful for treatment of cancer patient
EP4121403A4 (en) Nitro-aminoadamantane compounds for the treatment of betacoronavirus infections
EP3883552A4 (en) Cyanoaryl-aniline compounds for treatment of dermal disorders
EP3883567A4 (en) Naphthyridinone-aniline compounds for treatment of dermal disorders
EP3927375A4 (en) Compositions for disease treatment
EP3820477A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3744347A4 (en) Composition for skin diseases treatment use
AU2020901514A0 (en) Use of aminoacetonitrile compounds for the treatment of disease
AU2022298746A1 (en) Beta-lactam derivatives for the treatment of diseases
EP4069251A4 (en) Salts and polymorphs of cethromycin for the treatment of disease salts and polymorphs of cethromycin